The observed symptoms indicate that the femoral nerve has been affected. Although nerve damage during instrumental delivery is uncommon, it can occur during challenging deliveries and mid-cavity forceps use. The table below outlines the nerves that may be impacted by forceps and the corresponding clinical manifestations.
Nerve Clinical features
Femoral nerve Weakness in extending the knee, absence of the patellar reflex, and numbness in the thigh
Lumbosacral trunk Weakness in dorsiflexing the ankle and numbness in the calf and foot.

Selected Facts about Lower Limb Anatomy

The lower limb anatomy is a complex system that is often tested in medical examinations. One of the important aspects of this system is the nerves that control the motor and sensory functions of the lower limb. The femoral nerve, for example, controls knee extension and thigh flexion, and is responsible for the sensation in the anterior and medial aspect of the thigh and lower leg. This nerve is commonly injured in cases of hip and pelvic fractures, as well as stab or gunshot wounds.

Another important nerve is the obturator nerve, which controls thigh adduction and provides sensation to the medial thigh. Injuries to this nerve can occur in cases of anterior hip dislocation. The lateral cutaneous nerve of the thigh, on the other hand, does not control any motor function but is responsible for the sensation in the lateral and posterior surfaces of the thigh. Compression of this nerve near the ASIS can lead to meralgia paraesthetica, a condition characterized by pain, tingling, and numbness in the distribution of the lateral cutaneous nerve.

The tibial nerve controls foot plantarflexion and inversion and provides sensation to the sole of the foot. This nerve is not commonly injured as it is deep and well-protected. The common peroneal nerve, which controls foot dorsiflexion and eversion, is often injured at the neck of the fibula, resulting in foot drop. The superior gluteal nerve controls hip abduction and is commonly injured in cases of misplaced intramuscular injection, hip surgery, pelvic fracture, or posterior hip dislocation. Injury to this nerve results in a positive Trendelenburg sign. Finally, the inferior gluteal nerve controls hip extension and lateral rotation and is generally injured in association with the sciatic nerve. Injury to this nerve results in difficulty rising from a seated position, as well as an inability to jump or climb stairs.

The shoulder joint is stabilized by a group of muscles known as the rotator cuffs. To remember them, you can use the following order: Subscapularis, which is located on the front of your chest and assists with internal rotation of the shoulder; Supraspinatus, which runs parallel to your deltoid on top of your shoulder and is necessary for the first 20° of shoulder abduction before the deltoid takes over; and Infraspinatus, which is located on the upper back and helps with external rotation of the shoulder.

Understanding the Rotator Cuff Muscles

The rotator cuff muscles are a group of four muscles that are responsible for the movement and stability of the shoulder joint. These muscles include the supraspinatus, infraspinatus, teres minor, and subscapularis. Each muscle has a specific function that contributes to the overall movement of the shoulder.

The supraspinatus muscle is responsible for abducting the arm before the deltoid muscle. It is also the most commonly injured muscle in the rotator cuff. The infraspinatus muscle rotates the arm laterally, while the teres minor muscle adducts and rotates the arm laterally. Lastly, the subscapularis muscle adducts and rotates the arm medially.

Understanding the functions of each rotator cuff muscle is important in preventing injuries and maintaining shoulder health. By strengthening these muscles through targeted exercises, individuals can improve their shoulder stability and reduce the risk of injury.

The presence of Heberden’s nodes, which are bony swellings at the DIP joints, is a characteristic feature of osteoarthritis in the hand. Pain that worsens with activity, rather than rest, is also more indicative of OA than inflammatory arthritis. Psoriatic arthritis can cause swelling of the DIP joints, but the swelling is typically boggy rather than bony, and the pain tends to be worse in the morning and improve with activity. Reactive arthritis is unlikely to cause a DIP predominant arthritis, as it typically presents as a large joint lower limb oligoarthritis, and there is no recent history of infection. Rheumatoid arthritis does not typically affect the DIP joints.

Understanding Osteoarthritis of the Hand

Osteoarthritis of the hand, also known as nodal arthritis, is a condition that occurs when the cartilage at synovial joints is lost, leading to the degeneration of underlying bone. It is more common in women, usually presenting after the age of 55, and may have a genetic component. Risk factors include previous joint trauma, obesity, hypermobility, and certain occupations. Interestingly, osteoporosis may actually reduce the risk of developing hand OA.

Symptoms of hand OA include episodic joint pain, stiffness that worsens after periods of inactivity, and the development of painless bony swellings known as Heberden’s and Bouchard’s nodes. These nodes are the result of osteophyte formation and are typically found at the distal and proximal interphalangeal joints, respectively. In severe cases, there may be reduced grip strength and deformity of the carpometacarpal joint of the thumb, resulting in fixed adduction.

Diagnosis is typically made through X-ray, which may show signs of osteophyte formation and joint space narrowing before symptoms develop. While hand OA may not significantly impact a patient’s daily function, it is important to manage symptoms through pain relief and joint protection strategies. Additionally, the presence of hand OA may increase the risk of future hip and knee OA, particularly for hip OA.

Methylprednisolone, an intramuscular steroid, is commonly used to manage acute flares of rheumatoid arthritis. Glucocorticoids, such as methylprednisolone acetate and triamcinolone acetonide, are effective short-term treatment options that can be administered via intra-articular injection, intramuscular injection, or orally. Disease modifying anti-rheumatic drugs (DMARDs) like methotrexate may take several months to become effective, so they are not suitable for treating acute flare-ups. Non-steroidal anti-inflammatory drugs (NSAIDs) like naproxen can be used for a short period to reduce pain and inflammation, but their potential side effects and risks must be considered. Paracetamol can help with pain relief, but it does not address the inflammation associated with rheumatoid arthritis and is therefore not the most effective treatment option.

Managing Rheumatoid Arthritis with Disease-Modifying Therapies

The management of rheumatoid arthritis (RA) has significantly improved with the introduction of disease-modifying therapies (DMARDs) in the past decade. Patients with joint inflammation should start a combination of DMARDs as soon as possible, along with analgesia, physiotherapy, and surgery. In 2018, NICE updated their guidelines for RA management, recommending DMARD monotherapy with a short course of bridging prednisolone as the initial step. Monitoring response to treatment is crucial, and NICE suggests using a combination of CRP and disease activity to assess it. Flares of RA are often managed with corticosteroids, while methotrexate is the most widely used DMARD. Other DMARDs include sulfasalazine, leflunomide, and hydroxychloroquine. TNF-inhibitors are indicated for patients with an inadequate response to at least two DMARDs, including methotrexate. Etanercept, infliximab, and adalimumab are some of the TNF-inhibitors available, each with their own risks and administration methods. Rituximab and Abatacept are other DMARDs that can be used, but the latter is not currently recommended by NICE.

When systemic sclerosis leads to kidney problems, hypertension and AKI are common symptoms. The preferred treatment for this is ACE inhibitors, with lisinopril being the appropriate choice. In severe cases of sclerodermic renal crisis, microangiopathic haemolytic anaemia may also occur. Amlodipine is a calcium channel blocker used to manage hypertension, while bendroflumethiazide is a thiazide diuretic that can also be used for this purpose. Doxazosin, on the other hand, is an α blocker used to treat hypertension.

Understanding Systemic Sclerosis

Systemic sclerosis is a condition that affects the skin and other connective tissues, but its cause is unknown. It is more common in females, with three patterns of the disease. Limited cutaneous systemic sclerosis is characterised by Raynaud’s as the first sign, affecting the face and distal limbs, and associated with anti-centromere antibodies. CREST syndrome is a subtype of limited systemic sclerosis that includes Calcinosis, Raynaud’s phenomenon, oEsophageal dysmotility, Sclerodactyly, and Telangiectasia. Diffuse cutaneous systemic sclerosis affects the trunk and proximal limbs, associated with scl-70 antibodies, and has a poor prognosis. Respiratory involvement is the most common cause of death, with interstitial lung disease and pulmonary arterial hypertension being the primary complications. Renal disease and hypertension are also possible complications, and patients with renal disease should be started on an ACE inhibitor. Scleroderma without internal organ involvement is characterised by tightening and fibrosis of the skin, manifesting as plaques or linear. Antibodies such as ANA, RF, anti-scl-70, and anti-centromere are associated with different types of systemic sclerosis.

Rheumatoid arthritis is a symmetrical, polyarthritis that is characterized by early morning joint pain and stiffness. A positive prognosis is associated with negative anti-CCP antibodies and negative rheumatoid factor. When anti-CCP antibodies are present, they are usually seen in conjunction with positive rheumatoid factor, which is a strong predictor of early transformation from transient to persistent synovitis. A gradual onset of symptoms is also linked to a poor prognosis for rheumatoid arthritis, rather than a sudden onset. Additionally, female gender is associated with a worse prognosis for rheumatoid arthritis, while male gender is not. Finally, HLA-B27 is not associated with rheumatoid arthritis, but rather with seronegative spondyloarthropathies like psoriatic and reactive arthritis.

Prognostic Features of Rheumatoid Arthritis

A number of factors have been identified as predictors of a poor prognosis in patients with rheumatoid arthritis. These include being rheumatoid factor positive, having anti-CCP antibodies, presenting with poor functional status, showing early erosions on X-rays, having extra-articular features such as nodules, possessing the HLA DR4 gene, and experiencing an insidious onset. While there is some discrepancy regarding the association between gender and prognosis, both the American College of Rheumatology and the recent NICE guidelines suggest that female gender is linked to a poorer prognosis. It is important for healthcare professionals to be aware of these prognostic features in order to provide appropriate management and support for patients with rheumatoid arthritis.

Common Causes of Elbow Pain

Elbow pain can be caused by a variety of conditions, each with their own characteristic features. Lateral epicondylitis, also known as tennis elbow, is characterized by pain and tenderness localized to the lateral epicondyle. Pain is worsened by resisted wrist extension with the elbow extended or supination of the forearm with the elbow extended. Episodes typically last between 6 months and 2 years, with acute pain lasting for 6-12 weeks.

Medial epicondylitis, or golfer’s elbow, is characterized by pain and tenderness localized to the medial epicondyle. Pain is aggravated by wrist flexion and pronation, and symptoms may be accompanied by numbness or tingling in the 4th and 5th finger due to ulnar nerve involvement.

Radial tunnel syndrome is most commonly due to compression of the posterior interosseous branch of the radial nerve, and is thought to be a result of overuse. Symptoms are similar to lateral epicondylitis, but the pain tends to be around 4-5 cm distal to the lateral epicondyle. Symptoms may be worsened by extending the elbow and pronating the forearm.

Cubital tunnel syndrome is due to the compression of the ulnar nerve. Initially, patients may experience intermittent tingling in the 4th and 5th finger, which may be worse when the elbow is resting on a firm surface or flexed for extended periods. Later, numbness in the 4th and 5th finger with associated weakness may occur.

Olecranon bursitis is characterized by swelling over the posterior aspect of the elbow, with associated pain, warmth, and erythema. It typically affects middle-aged male patients. Understanding the characteristic features of these conditions can aid in their diagnosis and treatment.

The correct diagnosis for the patient in the vignette is primary hyperparathyroidism. This is indicated by the patient’s symptomatic hypercalcaemia, as well as their blood test results showing a raised calcium, reduced phosphate level, and a raised ALP. Multiple myeloma, Paget’s disease of bone, and sarcoidosis are all incorrect diagnoses as they do not match the patient’s symptoms and blood test results.

Lab Values for Bone Disorders

When it comes to bone disorders, certain lab values can provide important information for diagnosis and treatment. In cases of osteoporosis, calcium, phosphate, alkaline phosphatase (ALP), and parathyroid hormone (PTH) levels are typically within normal ranges. However, in osteomalacia, there is a decrease in calcium and phosphate levels, an increase in ALP levels, and an increase in PTH levels.

Primary hyperparathyroidism, which can lead to osteitis fibrosa cystica, is characterized by increased calcium and PTH levels, but decreased phosphate levels. Chronic kidney disease can also lead to secondary hyperparathyroidism, with decreased calcium levels and increased phosphate and PTH levels.

Paget’s disease, which causes abnormal bone growth, typically shows normal calcium and phosphate levels, but an increase in ALP levels. Osteopetrosis, a rare genetic disorder that causes bones to become dense and brittle, typically shows normal lab values for calcium, phosphate, ALP, and PTH.

Overall, understanding these lab values can help healthcare professionals diagnose and treat various bone disorders.

Patients who are newly diagnosed with dermatomyositis require an urgent screening for malignancy. The presence of proximal muscle weakness, heliotrope rash, and Gottron’s papules are indicative of dermatomyositis. It is important to investigate for underlying cancer, with common malignancies including lung, breast, ovarian, prostate, and colorectal. A malignancy screen may involve a chest x-ray, mammography, CA-125, pelvic ultrasound (in females), prostate-specific antigen (in males), faecal occult blood testing, and potentially a CT chest/abdomen/pelvis. Basic blood tests such as serum corrected calcium and LFTs should also be done as a quick screen for bone and liver metastases. Fundoscopy is not necessary in the absence of ocular symptoms. A pregnancy test is not required for this patient due to her age. A renal biopsy is only necessary if there is rheumatological renal disease or if systemic lupus erythematosus is suspected. However, the patient’s symptoms are more consistent with dermatomyositis.

Dermatomyositis is a condition that causes inflammation and muscle weakness, as well as distinct skin lesions. It can occur on its own or be associated with other connective tissue disorders or underlying cancers, particularly ovarian, breast, and lung cancer. Screening for cancer is often done after a diagnosis of dermatomyositis. Polymyositis is a variant of the disease that does not have prominent skin manifestations.

The skin features of dermatomyositis include a photosensitive macular rash on the back and shoulders, a heliotrope rash around the eyes, roughened red papules on the fingers’ extensor surfaces (known as Gottron’s papules), extremely dry and scaly hands with linear cracks on the fingers’ palmar and lateral aspects (known as mechanic’s hands), and nail fold capillary dilation. Other symptoms may include proximal muscle weakness with tenderness, Raynaud’s phenomenon, respiratory muscle weakness, interstitial lung disease (such as fibrosing alveolitis or organizing pneumonia), dysphagia, and dysphonia.

Investigations for dermatomyositis typically involve testing for ANA antibodies, which are positive in around 80% of patients. Approximately 30% of patients have antibodies to aminoacyl-tRNA synthetases, including antibodies against histidine-tRNA ligase (also called Jo-1), antibodies to signal recognition particle (SRP), and anti-Mi-2 antibodies.

According to the radiologist’s report, the patient has a stable Weber A fracture of the lateral malleolus (distal fibula) that is minimally displaced and located below the tibiofibular syndesmosis. As a result, immobilization in a back slab is unnecessary, and reduction is not required. RICE treatment is not recommended as it does not provide adequate immobilization, which can be an effective form of pain relief. Instead, a controlled ankle motion (CAM) boot is the appropriate management option as it allows weight-bearing while providing immobilization. Urgent surgical intervention is not necessary in this case due to the fracture’s stability and minimal displacement.

Ankle Fractures and their Classification

Ankle fractures are a common reason for emergency department visits. To minimize the unnecessary use of x-rays, the Ottawa ankle rules are used to aid in clinical examination. These rules state that x-rays are only necessary if there is pain in the malleolar zone and an inability to weight bear for four steps, tenderness over the distal tibia, or bone tenderness over the distal fibula. There are several classification systems for describing ankle fractures, including the Potts, Weber, and AO systems. The Weber system is the simplest and is based on the level of the fibular fracture. Type A is below the syndesmosis, type B fractures start at the level of the tibial plafond and may extend proximally to involve the syndesmosis, and type C is above the syndesmosis, which may itself be damaged. A subtype known as a Maisonneuve fracture may occur with a spiral fibular fracture that leads to disruption of the syndesmosis with widening of the ankle joint, requiring surgery.

Management of Ankle Fractures

The management of ankle fractures depends on the stability of the ankle joint and patient co-morbidities. Prompt reduction of all ankle fractures is necessary to relieve pressure on the overlying skin and prevent necrosis. Young patients with unstable, high velocity, or proximal injuries will usually require surgical repair, often using a compression plate. Elderly patients, even with potentially unstable injuries, usually fare better with attempts at conservative management as their thin bone does not hold metalwork well. It is important to consider the patient’s overall health and any other medical conditions when deciding on the best course of treatment.

This individual displays physical indications and a recent injury that are consistent with fat embolism syndrome. In the early stages, meningococcal sepsis is not commonly linked to hypoxia. Likewise, pyrexia is not typically associated with pulmonary emboli.

Understanding Fat Embolism: Diagnosis, Clinical Features, and Treatment

Fat embolism is a medical condition that occurs when fat globules enter the bloodstream and obstruct blood vessels. This condition is commonly seen in patients with long bone fractures, particularly in the femur and tibia. The diagnosis of fat embolism is based on clinical features, including respiratory symptoms such as tachypnea, dyspnea, and hypoxia, as well as dermatological symptoms such as a red or brown petechial rash. CNS symptoms such as confusion and agitation may also be present. Imaging may not always show vascular occlusion, but a ground glass appearance may be seen at the periphery.

Prompt fixation of long bone fractures is crucial in the treatment of fat embolism. However, there is some debate regarding the benefit versus risk of medullary reaming in femoral shaft or tibial fractures in terms of increasing the risk of fat embolism. DVT prophylaxis and general supportive care are also important in the management of this condition. While fat embolism can be a serious and potentially life-threatening condition, prompt diagnosis and treatment can improve outcomes for patients.

The symptoms and high ESR levels suggest that the patient may have polymyalgia rheumatica, with the added indication of painful mastication pointing towards possible temporal arthritis. Immediate treatment with high doses of steroids is crucial. To distinguish between polymyalgia rheumatica and statin-induced myopathy, ESR levels are typically measured. A significantly elevated ESR level would indicate polymyalgia rheumatica, while a normal ESR level would suggest statin myopathy.

Polymyalgia Rheumatica: A Condition of Muscle Stiffness in Older People

Polymyalgia rheumatica (PMR) is a common condition that affects older people. It is characterized by muscle stiffness and elevated inflammatory markers. Although it is closely related to temporal arthritis, the underlying cause is not fully understood, and it does not appear to be a vasculitic process. PMR typically affects patients over the age of 60 and has a rapid onset, usually within a month. Patients experience aching and morning stiffness in proximal limb muscles, along with mild polyarthralgia, lethargy, depression, low-grade fever, anorexia, and night sweats.

To diagnose PMR, doctors look for raised inflammatory markers, such as an ESR of over 40 mm/hr. Creatine kinase and EMG are normal. Treatment for PMR involves prednisolone, usually at a dose of 15 mg/od. Patients typically respond dramatically to steroids, and failure to do so should prompt consideration of an alternative diagnosis.

To confirm the diagnosis of spinal stenosis and rule out other potential causes like metastatic disease, an MRI is necessary for this presentation. The lower back pain that worsens with walking is a typical symptom of spinal stenosis.

Lower back pain is a common issue that is often caused by muscular strain. However, it is important to be aware of potential underlying causes that may require specific treatment. Certain red flags should be considered, such as age under 20 or over 50, a history of cancer, night pain, trauma, or systemic illness. There are also specific causes of lower back pain that should be kept in mind. Facet joint pain may be acute or chronic, worse in the morning and on standing, and typically worsens with back extension. Spinal stenosis may cause leg pain, numbness, and weakness that is worse on walking and relieved by sitting or leaning forward. Ankylosing spondylitis is more common in young men and causes stiffness that is worse in the morning and improves with activity. Peripheral arterial disease may cause pain on walking and weak foot pulses. It is important to consider these potential causes and seek appropriate diagnosis and treatment.

The symptoms indicate the possibility of antiphospholipid syndrome, which can be confirmed by a positive anti-Cardiolipin antibody test. It is crucial to keep in mind that hypercoagulable states and hyperviscosity can lead to strokes. Antiphospholipid syndrome is a type of thrombophilia disorder that causes hypercoagulation and a higher likelihood of forming clots, both arterial and venous. This increases the risk of ischaemic strokes.

Antiphospholipid syndrome is a condition that can be acquired and is characterized by a higher risk of both venous and arterial thrombosis, recurrent fetal loss, and thrombocytopenia. It can occur as a primary disorder or as a secondary condition to other diseases, with systemic lupus erythematosus being the most common. One important point to remember for exams is that antiphospholipid syndrome can cause a paradoxical increase in the APTT. This is due to an ex-vivo reaction of the lupus anticoagulant autoantibodies with phospholipids involved in the coagulation cascade. Other features of this condition include livedo reticularis, pre-eclampsia, and pulmonary hypertension.

Antiphospholipid syndrome can also be associated with other autoimmune disorders, lymphoproliferative disorders, and, rarely, phenothiazines. Management of this condition is based on EULAR guidelines. Primary thromboprophylaxis involves low-dose aspirin, while secondary thromboprophylaxis depends on the type of thromboembolic event. Initial venous thromboembolic events require lifelong warfarin with a target INR of 2-3, while recurrent venous thromboembolic events require lifelong warfarin and low-dose aspirin. Arterial thrombosis should be treated with lifelong warfarin with a target INR of 2-3.

The presence of DIP joint swelling and dactylitis in inflammatory arthritis suggests a diagnosis of psoriatic arthritis. Although there is not always a clear correlation between psoriatic arthritis and cutaneous psoriasis, arthritic symptoms often appear before skin lesions. While there may be some overlap with rheumatoid arthritis, the presence of DIP joint disease and dactylitis are more indicative of psoriatic arthritis. Gout is an unlikely diagnosis as it typically presents as acute and monoarticular or oligoarticular, without the other symptoms seen here. Osteoarthritis is also an unlikely diagnosis as it typically presents asymmetrically in larger joints and does not typically present with dactylitis or the findings seen on X-ray. Rheumatoid arthritis is a possibility, but a blood test for anti-cyclic citrullinated peptide antibodies (anti-CCP) should be performed to confirm the diagnosis, as these antibodies are highly specific to rheumatoid arthritis and are usually absent in psoriatic arthritis.

Psoriatic arthropathy is a type of inflammatory arthritis that is associated with psoriasis. It is classified as one of the seronegative spondyloarthropathies and is known to have a poor correlation with cutaneous psoriasis. In fact, it often precedes the development of skin lesions. This condition affects both males and females equally, with around 10-20% of patients with skin lesions developing an arthropathy.

The presentation of psoriatic arthropathy can vary, with different patterns of joint involvement. The most common type is symmetric polyarthritis, which is very similar to rheumatoid arthritis and affects around 30-40% of cases. Asymmetrical oligoarthritis is another type, which typically affects the hands and feet and accounts for 20-30% of cases. Sacroiliitis, DIP joint disease, and arthritis mutilans (severe deformity of fingers/hand) are other patterns of joint involvement. Other signs of psoriatic arthropathy include psoriatic skin lesions, periarticular disease, enthesitis, tenosynovitis, dactylitis, and nail changes.

To diagnose psoriatic arthropathy, X-rays are often used. These can reveal erosive changes and new bone formation, as well as periostitis and a pencil-in-cup appearance. Management of this condition should be done by a rheumatologist, and treatment is similar to that of rheumatoid arthritis. However, there are some differences, such as the use of monoclonal antibodies like ustekinumab and secukinumab. Mild peripheral arthritis or mild axial disease may be treated with NSAIDs alone, rather than all patients being on disease-modifying therapy as with RA. Overall, psoriatic arthropathy has a better prognosis than RA.

The inclusion of rheumatoid arthritis in the FRAX assessment tool highlights its significance as a risk factor for osteoporosis. This connection is likely due to various factors, such as increased use of corticosteroids, limited mobility caused by joint pain, and the impact of systemic inflammation on bone remodelling. Conversely, engaging in high-impact exercise, experiencing menopause later in life, and being of black ethnicity are all associated with a lower risk of developing osteoporosis. Additionally, recent research suggests that osteoporosis may actually increase the risk of ischaemic heart disease, rather than the other way around.

Understanding the Causes of Osteoporosis

Osteoporosis is a condition that affects the bones, making them weak and brittle. It is more common in women and older adults, with the prevalence increasing significantly in women over the age of 80. However, there are many other risk factors and secondary causes of osteoporosis that should be considered. Some of the most important risk factors include a history of glucocorticoid use, rheumatoid arthritis, alcohol excess, parental hip fracture, low body mass index, and smoking. Other risk factors include a sedentary lifestyle, premature menopause, certain ethnicities, and endocrine disorders such as hyperthyroidism and diabetes mellitus.

There are also medications that may worsen osteoporosis, such as SSRIs, antiepileptics, and proton pump inhibitors. If a patient is diagnosed with osteoporosis or has a fragility fracture, further investigations may be necessary to identify the cause and assess the risk of subsequent fractures. Recommended investigations include blood tests, bone densitometry, and other procedures as indicated. It is important to identify the cause of osteoporosis and contributory factors in order to select the most appropriate form of treatment. As a minimum, all patients should have a full blood count, urea and electrolytes, liver function tests, bone profile, CRP, and thyroid function tests.

For patients with antiphospholipid syndrome who have not experienced a thrombosis before, the recommended thromboprophylaxis is low-dose aspirin. The use of direct oral anticoagulants (DOACs) is not advised as studies have shown a higher incidence of clots in antiphospholipid patients on DOACs compared to warfarin. Low-molecular-weight heparin is not recommended for long-term use as it is administered subcutaneously. Warfarin with a target INR of 2-3 is appropriate only for patients who have previously suffered from venous or arterial clots.

Antiphospholipid syndrome is a condition that can be acquired and is characterized by a higher risk of both venous and arterial thrombosis, recurrent fetal loss, and thrombocytopenia. It can occur as a primary disorder or as a secondary condition to other diseases, with systemic lupus erythematosus being the most common. One important point to remember for exams is that antiphospholipid syndrome can cause a paradoxical increase in the APTT. This is due to an ex-vivo reaction of the lupus anticoagulant autoantibodies with phospholipids involved in the coagulation cascade. Other features of this condition include livedo reticularis, pre-eclampsia, and pulmonary hypertension.

Antiphospholipid syndrome can also be associated with other autoimmune disorders, lymphoproliferative disorders, and, rarely, phenothiazines. Management of this condition is based on EULAR guidelines. Primary thromboprophylaxis involves low-dose aspirin, while secondary thromboprophylaxis depends on the type of thromboembolic event. Initial venous thromboembolic events require lifelong warfarin with a target INR of 2-3, while recurrent venous thromboembolic events require lifelong warfarin and low-dose aspirin. Arterial thrombosis should be treated with lifelong warfarin with a target INR of 2-3.

In cases of suspected iliopsoas abscess, antibiotics alone are unlikely to provide a cure. If there is a high clinical suspicion of a retrocaecal appendix, urgent laparoscopy and IV antibiotics may be necessary. However, this condition typically presents with acute pain in the right lower quadrant of the abdomen upon hip extension. Neoplastic spinal cord compression may require oral dexamethasone and an oncological review, as it initially presents with back pain and can progress to neurological deficits.

An iliopsoas abscess is a condition where pus accumulates in the iliopsoas compartment, which includes the iliacus and psoas muscles. There are two types of iliopsoas abscesses: primary and secondary. Primary abscesses occur due to the spread of bacteria through the bloodstream, with Staphylococcus aureus being the most common cause. Secondary abscesses are caused by underlying conditions such as Crohn’s disease, diverticulitis, colorectal cancer, UTIs, GU cancers, vertebral osteomyelitis, femoral catheterization, lithotripsy, endocarditis, and intravenous drug use. Secondary abscesses have a higher mortality rate compared to primary abscesses.

The clinical features of an iliopsoas abscess include fever, back/flank pain, limp, and weight loss. During a clinical examination, the patient is positioned supine with the knee flexed and the hip mildly externally rotated. Specific tests are performed to diagnose iliopsoas inflammation, such as placing a hand proximal to the patient’s ipsilateral knee and asking the patient to lift their thigh against the hand, which causes pain due to contraction of the psoas muscle. Another test involves lying the patient on the normal side and hyperextending the affected hip, which should elicit pain as the psoas muscle is stretched.

The investigation of choice for an iliopsoas abscess is a CT scan of the abdomen. Management involves antibiotics and percutaneous drainage, which is successful in around 90% of cases. Surgery is only indicated if percutaneous drainage fails or if there is another intra-abdominal pathology that requires surgery.

The most likely diagnosis for a malignant tumour occurring in the diaphysis of the pelvis and long bones, which mainly affects children and adolescents and presents with severe pain and an onion skin appearance on X-ray, is Ewing’s sarcoma. Fine-needle aspiration may be performed to confirm the diagnosis, with the presence of EWS-FLI1 protein being a key finding. Chondrosarcoma, osteoma, and osteochondroma are unlikely diagnoses as they present differently and affect different age groups.

Types of Bone Tumours

Bone tumours can be classified into two categories: benign and malignant. Benign tumours are non-cancerous and do not spread to other parts of the body. Osteoma is a common benign tumour that occurs on the skull and is associated with Gardner’s syndrome. Osteochondroma, on the other hand, is the most common benign bone tumour and is usually diagnosed in patients aged less than 20 years. It is characterized by a cartilage-capped bony projection on the external surface of a bone. Giant cell tumour is a tumour of multinucleated giant cells within a fibrous stroma and is most commonly seen in the epiphysis of long bones.

Malignant tumours, on the other hand, are cancerous and can spread to other parts of the body. Osteosarcoma is the most common primary malignant bone tumour and is mainly seen in children and adolescents. It occurs most frequently in the metaphyseal region of long bones prior to epiphyseal closure. Ewing’s sarcoma is a small round blue cell tumour that is also seen mainly in children and adolescents. It occurs most frequently in the pelvis and long bones and tends to cause severe pain. Chondrosarcoma is a malignant tumour of cartilage that most commonly affects the axial skeleton and is more common in middle-age. It is important to diagnose and treat bone tumours early to prevent complications and improve outcomes.

Joint Replacement for Osteoarthritis

Joint replacement, also known as arthroplasty, is the most effective treatment for patients with osteoarthritis who experience significant pain. Around 25% of patients are now younger than 60 years old, and while obesity is often thought to be a barrier to joint replacement, there is only a slight increase in short-term complications. There is no difference in long-term joint replacement survival.

For hips, the most common type of operation is a cemented hip replacement, where a metal femoral component is cemented into the femoral shaft, accompanied by a cemented acetabular polyethylene cup. However, uncemented hip replacements are becoming increasingly popular, particularly in younger and more active patients, despite being more expensive than conventional cemented hip replacements. Hip resurfacing is also sometimes used, where a metal cap is attached over the femoral head, often in younger patients, and has the advantage of preserving the femoral neck, which may be useful if conventional arthroplasty is needed later in life.

Post-operative recovery involves both physiotherapy and a course of home-exercises. Walking sticks or crutches are usually used for up to 6 weeks after hip or knee replacement surgery. Patients who have had a hip replacement operation should receive basic advice to minimize the risk of dislocation, such as avoiding flexing the hip more than 90 degrees, avoiding low chairs, not crossing their legs, and sleeping on their back for the first 6 weeks.

Complications of joint replacement surgery include wound and joint infection, thromboembolism, and dislocation. NICE recommends that patients receive low-molecular weight heparin for 4 weeks following a hip replacement to reduce the risk of thromboembolism.

The patient’s symptoms of swelling and pain in the distal interphalangeal joints and dactylitis suggest a diagnosis of psoriatic arthritis. This is further supported by her use of a prescription coal tar shampoo for psoriatic lesions on her scalp. Psoriatic joint disease can cause a distinct X-ray appearance known as a pencil-in-cup deformity, characterized by periarticular erosions and bone resorption.

In contrast, erosions with overhanging edges, also known as rat-bite erosions, are associated with gout and tophi, typically affecting the first metatarsal joint in the foot. Joint effusion may be present in the early stages of septic arthritis, which should be ruled out for any hot, painful swollen joint. However, the patient’s lack of systemic illness and unchanged swelling over time make septic arthritis less likely.

Osteoarthritis, a non-inflammatory degenerative arthritis that worsens with age, does not typically present with dactylitis and is characterized by X-ray features such as loss of joint space, osteophytes, and subchondral sclerosis.

Psoriatic arthropathy is a type of inflammatory arthritis that is associated with psoriasis. It is classified as one of the seronegative spondyloarthropathies and is known to have a poor correlation with cutaneous psoriasis. In fact, it often precedes the development of skin lesions. This condition affects both males and females equally, with around 10-20% of patients with skin lesions developing an arthropathy.

The presentation of psoriatic arthropathy can vary, with different patterns of joint involvement. The most common type is symmetric polyarthritis, which is very similar to rheumatoid arthritis and affects around 30-40% of cases. Asymmetrical oligoarthritis is another type, which typically affects the hands and feet and accounts for 20-30% of cases. Sacroiliitis, DIP joint disease, and arthritis mutilans (severe deformity of fingers/hand) are other patterns of joint involvement. Other signs of psoriatic arthropathy include psoriatic skin lesions, periarticular disease, enthesitis, tenosynovitis, dactylitis, and nail changes.

To diagnose psoriatic arthropathy, X-rays are often used. These can reveal erosive changes and new bone formation, as well as periostitis and a pencil-in-cup appearance. Management of this condition should be done by a rheumatologist, and treatment is similar to that of rheumatoid arthritis. However, there are some differences, such as the use of monoclonal antibodies like ustekinumab and secukinumab. Mild peripheral arthritis or mild axial disease may be treated with NSAIDs alone, rather than all patients being on disease-modifying therapy as with RA. Overall, psoriatic arthropathy has a better prognosis than RA.

Isoniazid is the tuberculosis antibiotic that can lead to drug-induced lupus. Drug-induced lupus is a condition that shares some symptoms with systemic lupus erythematosus (SLE), but not all. It usually goes away once the patient stops taking the medication. Anti-histone antibodies are typically positive in drug-induced lupus, but less common in SLE. On the other hand, anti-dsDNA antibodies are present in more than half of SLE cases, but very rarely in drug-induced lupus. Procainamide and hydralazine are the most common drugs that cause drug-induced lupus, but isoniazid is the most likely cause from the list of tuberculosis antibiotics (and pyridoxine). Isoniazid is also known to cause peripheral neuropathy and hepatitis. Ethambutol is another tuberculosis antibiotic that does not cause drug-induced lupus, but can cause optic neuritis. Pyrazinamide is another tuberculosis antibiotic that does not cause drug-induced lupus, but can cause gout and hepatitis. Pyridoxine is vitamin B6 and is given to all patients taking isoniazid to prevent peripheral neuropathy. It does not cause drug-induced lupus.

Understanding Drug-Induced Lupus

Drug-induced lupus is a condition that shares some similarities with systemic lupus erythematosus, but not all of its typical features are present. Unlike SLE, renal and nervous system involvement is rare in drug-induced lupus. The good news is that this condition usually resolves once the drug causing it is discontinued.

The most common symptoms of drug-induced lupus include joint pain, muscle pain, skin rashes (such as the malar rash), and pulmonary issues like pleurisy. In terms of laboratory findings, patients with drug-induced lupus typically test positive for ANA (antinuclear antibodies) but negative for dsDNA (double-stranded DNA) antibodies. Anti-histone antibodies are found in 80-90% of cases, while anti-Ro and anti-Smith antibodies are only present in around 5% of cases.

The most common drugs that can cause drug-induced lupus are procainamide and hydralazine. Other less common culprits include isoniazid, minocycline, and phenytoin.

The most specific test for diffuse cutaneous systemic sclerosis among patients is the presence of anti-Scl-70 antibodies.

Understanding Systemic Sclerosis

Systemic sclerosis is a condition that affects the skin and other connective tissues, but its cause is unknown. It is more common in females, with three patterns of the disease. Limited cutaneous systemic sclerosis is characterised by Raynaud’s as the first sign, affecting the face and distal limbs, and associated with anti-centromere antibodies. CREST syndrome is a subtype of limited systemic sclerosis that includes Calcinosis, Raynaud’s phenomenon, oEsophageal dysmotility, Sclerodactyly, and Telangiectasia. Diffuse cutaneous systemic sclerosis affects the trunk and proximal limbs, associated with scl-70 antibodies, and has a poor prognosis. Respiratory involvement is the most common cause of death, with interstitial lung disease and pulmonary arterial hypertension being the primary complications. Renal disease and hypertension are also possible complications, and patients with renal disease should be started on an ACE inhibitor. Scleroderma without internal organ involvement is characterised by tightening and fibrosis of the skin, manifesting as plaques or linear. Antibodies such as ANA, RF, anti-scl-70, and anti-centromere are associated with different types of systemic sclerosis.

Understanding Drug-Induced Lupus

Drug-induced lupus is a condition that shares some similarities with systemic lupus erythematosus, but not all of its typical features are present. Unlike SLE, renal and nervous system involvement is rare in drug-induced lupus. The good news is that this condition usually resolves once the drug causing it is discontinued.

The most common symptoms of drug-induced lupus include joint pain, muscle pain, skin rashes (such as the malar rash), and pulmonary issues like pleurisy. In terms of laboratory findings, patients with drug-induced lupus typically test positive for ANA (antinuclear antibodies) but negative for dsDNA (double-stranded DNA) antibodies. Anti-histone antibodies are found in 80-90% of cases, while anti-Ro and anti-Smith antibodies are only present in around 5% of cases.

The most common drugs that can cause drug-induced lupus are procainamide and hydralazine. Other less common culprits include isoniazid, minocycline, and phenytoin.

If a patient has a known allergy to a sulfa drug like co-trimoxazole, they should avoid taking sulfasalazine. However, hydroxychloroquine, leflunomide, methotrexate, and sarilumab are not contraindicated for this patient. These drugs may be considered as first-line treatments for rheumatoid arthritis, depending on the patient’s disease activity and response to other medications. It is important to note that sulfasalazine should be avoided in patients with a sulfa drug allergy.

Sulfasalazine: A DMARD for Inflammatory Arthritis and Bowel Disease

Sulfasalazine is a type of disease modifying anti-rheumatic drug (DMARD) that is commonly used to manage inflammatory arthritis, particularly rheumatoid arthritis, as well as inflammatory bowel disease. This medication is a prodrug for 5-ASA, which works by reducing neutrophil chemotaxis and suppressing the proliferation of lymphocytes and pro-inflammatory cytokines.

However, caution should be exercised when using sulfasalazine in patients with G6PD deficiency or those who are allergic to aspirin or sulphonamides due to the risk of cross-sensitivity. Adverse effects of sulfasalazine may include oligospermia, Stevens-Johnson syndrome, pneumonitis/lung fibrosis, myelosuppression, Heinz body anaemia, megaloblastic anaemia, and the potential to color tears and stain contact lenses.

Despite these potential side effects, sulfasalazine is considered safe to use during pregnancy and breastfeeding, making it a viable option for women who require treatment for inflammatory arthritis or bowel disease. Overall, sulfasalazine is an effective DMARD that can help manage the symptoms of these conditions and improve patients’ quality of life.

Patients who have a hypersensitivity to aspirin may also experience an allergic reaction to sulfasalazine. This is important to note as sulfasalazine is a DMARD used to treat rheumatoid arthritis, particularly in cases where other treatments have not been effective. The patient in this case has refractory rheumatoid arthritis, indicating that the recent medication change is likely a rheumatic agent.

While ACE inhibitors like ramipril can cause angioedema and difficulty breathing, it is not typically associated with urticaria. This is because drug-induced angioedema is usually caused by bradykinin, not histamine.

Cetirizine is an antihistamine that can provide relief for symptoms such as urticaria, histamine-mediated angioedema, and anaphylactic reactions.

Omeprazole is a PPI that is used to treat conditions like gastro-oesophageal reflux disease by suppressing acidic gastric secretions. While skin reactions can occur with the use of omeprazole, bronchospasm is considered rare or very rare according to the BNF. In this case, the most likely culprit for the patient’s allergic reaction is sulfasalazine due to their known aspirin allergy.

Sulfasalazine: A DMARD for Inflammatory Arthritis and Bowel Disease

Sulfasalazine is a type of disease modifying anti-rheumatic drug (DMARD) that is commonly used to manage inflammatory arthritis, particularly rheumatoid arthritis, as well as inflammatory bowel disease. This medication is a prodrug for 5-ASA, which works by reducing neutrophil chemotaxis and suppressing the proliferation of lymphocytes and pro-inflammatory cytokines.

However, caution should be exercised when using sulfasalazine in patients with G6PD deficiency or those who are allergic to aspirin or sulphonamides due to the risk of cross-sensitivity. Adverse effects of sulfasalazine may include oligospermia, Stevens-Johnson syndrome, pneumonitis/lung fibrosis, myelosuppression, Heinz body anaemia, megaloblastic anaemia, and the potential to color tears and stain contact lenses.

Despite these potential side effects, sulfasalazine is considered safe to use during pregnancy and breastfeeding, making it a viable option for women who require treatment for inflammatory arthritis or bowel disease. Overall, sulfasalazine is an effective DMARD that can help manage the symptoms of these conditions and improve patients’ quality of life.

This woman has classic symptoms of systemic lupus erythematosus (SLE), including a malar rash, polyarthritis, and Raynaud’s syndrome. A positive blood test for anti-dsDNA confirms the diagnosis. The main treatment for SLE is hydroxychloroquine, along with NSAIDs and steroids. However, there is a significant risk of severe and permanent retinopathy associated with hydroxychloroquine use. Therefore, the Royal College of Ophthalmologists recommends monitoring for retinopathy at baseline and every 6-12 months while on treatment. Visual acuity testing is a reasonable way to monitor for this. Routine monitoring of calcium levels, hearing, liver function, and neurological deficits of the limbs is not necessary as there is no evidence of hydroxychloroquine affecting these areas.

Hydroxychloroquine: Uses and Adverse Effects

Hydroxychloroquine is a medication commonly used in the treatment of rheumatoid arthritis and systemic/discoid lupus erythematosus. It is similar to chloroquine, which is used to treat certain types of malaria. However, hydroxychloroquine has been found to cause bull’s eye retinopathy, which can result in severe and permanent visual loss. Recent data suggests that this adverse effect is more common than previously thought, and the most recent guidelines recommend baseline ophthalmological examination and annual screening, including colour retinal photography and spectral domain optical coherence tomography scanning of the macula. Despite this risk, hydroxychloroquine may still be used in pregnant women if needed. Patients taking this medication should be asked about visual symptoms and have their visual acuity monitored annually using a standard reading chart.

Managing Fibromyalgia: A Multidisciplinary Approach

Fibromyalgia is a syndrome that causes widespread pain throughout the body, particularly in specific anatomical sites. It is more common in women and typically presents between the ages of 30-50. Other features include lethargy, cognitive impairment, sleep disturbance, headaches, and dizziness. Diagnosis is clinical and based on the presence of tender points on the body. Management of fibromyalgia is often difficult and requires a tailored, multidisciplinary approach. While there is a lack of evidence and guidelines to guide practice, consensus guidelines from the European League against Rheumatism (EULAR) and a BMJ review suggest that aerobic exercise, cognitive behavioural therapy, and medication such as pregabalin, duloxetine, and amitriptyline may be helpful.

Managing fibromyalgia requires a comprehensive approach that addresses the physical, emotional, and psychological aspects of the condition. While there is no cure for fibromyalgia, a combination of treatments can help manage symptoms and improve quality of life. Aerobic exercise has the strongest evidence base and can help reduce pain and fatigue. Cognitive behavioural therapy can help patients develop coping strategies and improve their mental health. Medications such as pregabalin, duloxetine, and amitriptyline can also be effective in managing pain and other symptoms. However, it is important to note that treatment should be tailored to the individual patient and may require a trial-and-error approach. With a multidisciplinary approach, patients with fibromyalgia can find relief and improve their overall well-being.

When a psoas abscess is suspected, CT abdomen is the recommended diagnostic test. Tom has presented with right-sided abdominal pain that is relieved by hip flexion, along with a positive psoas sign and a low-grade fever, which are indicative of psoas abscess. Although MRI has a similar sensitivity to contrast CT, it is less accessible. Retrocaecal appendicitis is less likely based on Tom’s history and examination. While abdominal ultrasound is preferred for investigating appendicitis in children and pregnant women, abdominopelvic CT is preferred for other adults. Hip x-ray is not the most useful test in this case, as osteomyelitis or avascular necrosis are less likely based on Tom’s clinical presentation. Colonoscopy is not the most appropriate test to order next, as his symptoms are unlikely to be caused by a flare-up of his Crohn’s disease.

An iliopsoas abscess is a condition where pus accumulates in the iliopsoas compartment, which includes the iliacus and psoas muscles. There are two types of iliopsoas abscesses: primary and secondary. Primary abscesses occur due to the spread of bacteria through the bloodstream, with Staphylococcus aureus being the most common cause. Secondary abscesses are caused by underlying conditions such as Crohn’s disease, diverticulitis, colorectal cancer, UTIs, GU cancers, vertebral osteomyelitis, femoral catheterization, lithotripsy, endocarditis, and intravenous drug use. Secondary abscesses have a higher mortality rate compared to primary abscesses.

The clinical features of an iliopsoas abscess include fever, back/flank pain, limp, and weight loss. During a clinical examination, the patient is positioned supine with the knee flexed and the hip mildly externally rotated. Specific tests are performed to diagnose iliopsoas inflammation, such as placing a hand proximal to the patient’s ipsilateral knee and asking the patient to lift their thigh against the hand, which causes pain due to contraction of the psoas muscle. Another test involves lying the patient on the normal side and hyperextending the affected hip, which should elicit pain as the psoas muscle is stretched.

The investigation of choice for an iliopsoas abscess is a CT scan of the abdomen. Management involves antibiotics and percutaneous drainage, which is successful in around 90% of cases. Surgery is only indicated if percutaneous drainage fails or if there is another intra-abdominal pathology that requires surgery.

Ankylosing spondylitis is primarily managed through exercise and NSAIDs. NSAIDs are effective in relieving symptoms and preventing functional limitations, while regular exercise, including postural training, range of motion exercises, stretching, and recreational activities like swimming, can help reduce and prevent functional limitations.

To measure disease activity, the Ankylosing Spondylitis Disease Activity Score (ASDAS) is used, which categorizes disease activity as inactive, low, high, or very high. If a patient has persistently high disease activity despite conventional treatments with NSAIDs, anti-tumor necrosis factor (TNF) therapy may be considered. However, the disease activity must be at least high (≥2.1) on ASDAS to warrant biologic therapy.

Glucocorticoids are not recommended for patients with ankylosing spondylitis. Methotrexate may be prescribed if conventional treatment with NSAIDs does not control symptoms, specifically for persistent peripheral arthritis.

In severe cases where the disease has progressed, surgery may be necessary. Hip and spine surgery may be beneficial for select patients with persistent pain or severe limitation in mobility, neurologic impairment, or severe flexion deformities.

Investigating and Managing Ankylosing Spondylitis

Ankylosing spondylitis is a type of spondyloarthropathy that is associated with HLA-B27. It is more commonly seen in males aged 20-30 years old. Inflammatory markers such as ESR and CRP are usually elevated, but normal levels do not necessarily rule out ankylosing spondylitis. HLA-B27 is not a reliable diagnostic tool as it can also be positive in normal individuals. The most effective way to diagnose ankylosing spondylitis is through a plain x-ray of the sacroiliac joints. However, if the x-ray is negative but suspicion for AS remains high, an MRI can be obtained to confirm the diagnosis.

Management of ankylosing spondylitis involves regular exercise, such as swimming, and the use of NSAIDs as the first-line treatment. Physiotherapy can also be helpful. Disease-modifying drugs used for rheumatoid arthritis, such as sulphasalazine, are only useful if there is peripheral joint involvement. Anti-TNF therapy, such as etanercept and adalimumab, should be given to patients with persistently high disease activity despite conventional treatments, according to the 2010 EULAR guidelines. Ongoing research is being conducted to determine whether anti-TNF therapies should be used earlier in the course of the disease. Spirometry may show a restrictive defect due to a combination of pulmonary fibrosis, kyphosis, and ankylosis of the costovertebral joints.

Phalen’s test is utilized for evaluating carpal tunnel syndrome by holding the patient’s wrist in maximum flexion (reverse prayer sign) for 30-60 seconds. A positive result is indicated by numbness in the median nerve distribution.

This scenario is typical of carpal tunnel syndrome, which affects the thenar muscles and provides sensory innervation to the lateral three and a half digits. The compression of the median nerve during Phalen’s test leads to the aforementioned presentation.

In contrast, cubital tunnel syndrome results from ulnar nerve compression and causes hypothenar muscle wasting and numbness in the medial one and a half digits. Ulnar nerve injury leads to loss of sensation in the medial one and a half digit, while radial nerve palsy typically presents with wrist drop and loss of sensation in the first dorsal web-space.

Finally, radial ganglion is characterized by a mass near the base of the thumb, usually above the wrist.

Nerve Signs for Assessing Ulnar Nerve Palsy and Carpal Tunnel Syndrome

Nerve signs are important diagnostic tools for assessing ulnar nerve palsy and carpal tunnel syndrome. Two commonly used nerve signs are Froment’s sign and Phalen’s test. Froment’s sign is used to assess for ulnar nerve palsy by testing the function of the adductor pollicis muscle. The patient is asked to hold a piece of paper between their thumb and index finger, which is then pulled away. If the patient is unable to hold the paper and flexes the flexor pollicis longus to compensate, it indicates ulnar nerve palsy.

Phalen’s test is used to assess carpal tunnel syndrome and is more sensitive than Tinel’s sign. The patient’s wrist is held in maximum flexion, and the test is positive if there is numbness in the median nerve distribution. Tinel’s sign is also used to assess for carpal tunnel syndrome by tapping the median nerve at the wrist. The test is positive if there is tingling or electric-like sensations over the distribution of the median nerve.

In summary, nerve signs are useful diagnostic tools for assessing ulnar nerve palsy and carpal tunnel syndrome. Froment’s sign and Phalen’s test are two commonly used nerve signs that can help healthcare professionals make an accurate diagnosis.

Osteogenesis imperfecta, also known as brittle bone disease, typically presents with normal levels of adjusted calcium, PTH, ALP, and PO4. This group of disorders affects collagen metabolism, resulting in bone fragility and susceptibility to fractures. The mildest and most common form is type 1, which is usually diagnosed in childhood and may present with blue sclera, dental imperfections, and deafness due to otosclerosis.

Primary hyperparathyroidism may present with raised adjusted calcium and PTH levels, normal or raised ALP levels, and low PO4 levels. Hypoparathyroidism may present with low adjusted calcium and PTH levels, normal ALP levels, and raised PO4 levels. Secondary hyperparathyroidism may present with low adjusted calcium, high PTH levels, normal ALP levels, and variable PO4 levels. Malignant PTH-related protein, which can occur in certain cancers such as squamous cell lung cancer, may present with raised adjusted calcium, low PTH levels, raised ALP levels, and raised PO4 levels, with normal ALP levels also possible.

Osteogenesis imperfecta, also known as brittle bone disease, is a group of disorders that affect collagen metabolism, leading to bone fragility and fractures. The most common type of osteogenesis imperfecta is type 1, which is inherited in an autosomal dominant manner and is caused by a decrease in the synthesis of pro-alpha 1 or pro-alpha 2 collagen polypeptides. This condition typically presents in childhood and is characterized by fractures that occur following minor trauma, as well as blue sclera, dental imperfections, and deafness due to otosclerosis.

When investigating osteogenesis imperfecta, it is important to note that adjusted calcium, phosphate, parathyroid hormone, and ALP results are usually normal. This condition can have a significant impact on a person’s quality of life, as it can lead to frequent fractures and other complications. However, with proper management and support, individuals with osteogenesis imperfecta can lead fulfilling lives.

A joint aspiration is recommended for this patient who presents with new-onset monoarticular arthritis and no confirmed diagnosis of rheumatoid arthritis. In cases of rheumatoid arthritis, the synovial fluid will typically appear yellow and have increased opacity due to the quantity of leukocytes present. The leukocyte count can range from 2,000 to 50,000 per microlitre, with a predominance of polymorphonuclear neutrophils (PMNs). There will be no crystals present. Despite the patient’s atypical history of rheumatoid arthritis, the arthrocentesis findings, along with their past medical history of systemic lupus erythematosus (SLE) and the presence of constitutional symptoms and an Achilles tendon nodule, support the diagnosis of rheumatoid arthritis. Gout, osteoarthritis, and pseudogout can be ruled out based on the absence of their characteristic arthrocentesis findings.

Rheumatoid Arthritis: Symptoms and Presentations

Rheumatoid arthritis is a chronic autoimmune disease that primarily affects the joints, causing pain, swelling, and stiffness. The typical features of rheumatoid arthritis include swollen and painful joints in the hands and feet, with stiffness being worse in the morning. The condition gradually worsens over time, with larger joints becoming involved. The presentation of rheumatoid arthritis usually develops insidiously over a few months, and a positive ‘squeeze test’ may be observed, which causes discomfort on squeezing across the metacarpal or metatarsal joints.

Late features of rheumatoid arthritis include Swan neck and boutonnière deformities, which are unlikely to be present in a recently diagnosed patient. However, other presentations of rheumatoid arthritis may include an acute onset with marked systemic disturbance or relapsing/remitting monoarthritis of different large joints, known as palindromic rheumatism. It is important to recognize the symptoms and presentations of rheumatoid arthritis to ensure prompt diagnosis and treatment.

The patient is exhibiting symptoms of adult-onset Still’s disease, including fever, polyarthralgia, and rash. The elevated ferritin levels also suggest this diagnosis, as ferritin is commonly used to monitor disease activity in these patients. It is important to note that severe flares of this disease can mimic sepsis. Treatment options include biologic therapies like anti-TNFs and anakinra, as well as traditional DMARDs and non-steroidal anti-inflammatory drugs. While rheumatoid arthritis is a possible differential diagnosis, the triad of symptoms is more commonly associated with Still’s disease. Septic arthritis typically presents as monoarthritis or oligoarthritis, not polyarthritis. Additionally, the rash described is not indicative of psoriasis. It is worth noting that this is a case of adult-onset Still’s disease, as the patient began experiencing symptoms in their twenties.

Still’s disease in adults is a condition that has a bimodal age distribution, affecting individuals between the ages of 15-25 years and 35-46 years. The disease is characterized by symptoms such as arthralgia, elevated serum ferritin, a salmon-pink maculopapular rash, pyrexia, lymphadenopathy, and a daily pattern of worsening joint symptoms and rash in the late afternoon or early evening. The disease is typically diagnosed using the Yamaguchi criteria, which has a sensitivity of 93.5% and is the most widely used criteria for diagnosis.

Managing Still’s disease in adults can be challenging, and treatment options include NSAIDs as a first-line therapy to manage fever, joint pain, and serositis. It is recommended that NSAIDs be trialed for at least a week before steroids are added. While steroids may control symptoms, they do not improve prognosis. If symptoms persist, the use of methotrexate, IL-1, or anti-TNF therapy can be considered.

To prevent pathological fractures in bone metastases, bisphosphonates and denosumab are viable options. However, if the patient’s eGFR is less than 30, denosumab is the preferred choice. Alendronic acid should be avoided due to the patient’s history of severe reflux during previous use. Denosumab is a novel treatment for osteoporosis that inhibits the development of osteoclasts by blocking RANKL. It is administered via subcutaneous injection and is also effective in preventing skeletal-related events in adults with bone metastases from solid tumors. Cinacalcet is not indicated for the management of osteoporosis or pathological fractures, but rather for hyperparathyroidism and hypercalcemia in parathyroid carcinoma. Hormone-replacement therapy (HRT) is not recommended for the treatment of osteoporosis in older postmenopausal women due to its unfavorable risk-benefit ratio.

Denosumab: A New Treatment for Osteoporosis

Denosumab is a human monoclonal antibody that inhibits the development of osteoclasts, which are responsible for breaking down bone tissue. It is administered as a subcutaneous injection every six months at a dose of 60mg. A larger dose of 120mg may be given every four weeks to prevent skeletal-related events in adults with bone metastases from solid tumors.

When it comes to managing osteoporosis, oral bisphosphonates are still the first-line treatment, with alendronate being the preferred option. If alendronate is not tolerated, an alternative bisphosphonate such as risedronate or etidronate may be used. Next-line medications are only started if certain T score and other risk factor criteria are met. Raloxifene and strontium ranelate were previously recommended as next-line drugs, but due to safety concerns regarding strontium ranelate, denosumab is becoming increasingly popular.

Denosumab is generally well-tolerated, with dyspnea and diarrhea being the most common side effects. However, doctors should be aware of the potential for atypical femoral fractures in patients taking denosumab and should look out for patients complaining of unusual thigh, hip, or groin pain.

Overall, denosumab is a promising new treatment for osteoporosis that may be particularly useful for patients who cannot tolerate oral bisphosphonates or who have other risk factors that make them unsuitable for these medications.

Hip fracture surgery aims to enable immediate weight bearing to reduce complications associated with immobility. The BOA recommends unrestricted weight bearing to shorten hospital stays and improve patient compliance. The dynamic hip screw requires weight bearing for proper compression of the fracture site.

Hip fractures are a common occurrence, particularly in elderly women with osteoporosis. The femoral head’s blood supply runs up the neck, making avascular necrosis a potential risk in displaced fractures. Symptoms of a hip fracture include pain and a shortened and externally rotated leg. Patients with non-displaced or incomplete neck of femur fractures may still be able to bear weight. Hip fractures can be classified as intracapsular or extracapsular, with the Garden system being a commonly used classification system. Blood supply disruption is most common in Types III and IV fractures.

Intracapsular hip fractures can be treated with internal fixation or hemiarthroplasty if the patient is unfit. Displaced fractures are recommended for replacement arthroplasty, such as total hip replacement or hemiarthroplasty, according to NICE guidelines. Total hip replacement is preferred over hemiarthroplasty if the patient was able to walk independently outdoors with the use of a stick, is not cognitively impaired, and is medically fit for anesthesia and the procedure. Extracapsular hip fractures can be managed with a dynamic hip screw for stable intertrochanteric fractures or an intramedullary device for reverse oblique, transverse, or subtrochanteric fractures.

The presence of anti-histone antibodies is associated with drug-induced lupus, which is the most likely cause of the symmetrical annular papulosquamous lesions on sun-exposed areas in this patient who is currently taking isoniazid. Anti-Ro antibodies are not relevant as they are commonly associated with Sjogren’s syndrome, while anti-centromere antibodies are associated with limited systemic sclerosis. Anti-double stranded DNA antibodies are associated with systemic lupus erythematosus, which is less likely in this patient given her age and clinical presentation.

Understanding Drug-Induced Lupus

Drug-induced lupus is a condition that shares some similarities with systemic lupus erythematosus, but not all of its typical features are present. Unlike SLE, renal and nervous system involvement is rare in drug-induced lupus. The good news is that this condition usually resolves once the drug causing it is discontinued.

The most common symptoms of drug-induced lupus include joint pain, muscle pain, skin rashes (such as the malar rash), and pulmonary issues like pleurisy. In terms of laboratory findings, patients with drug-induced lupus typically test positive for ANA (antinuclear antibodies) but negative for dsDNA (double-stranded DNA) antibodies. Anti-histone antibodies are found in 80-90% of cases, while anti-Ro and anti-Smith antibodies are only present in around 5% of cases.

The most common drugs that can cause drug-induced lupus are procainamide and hydralazine. Other less common culprits include isoniazid, minocycline, and phenytoin.

The 2016 NICE guidelines suggest considering oral non-steroidal anti-inflammatory drugs (NSAIDs) for the management of low back pain, while taking into account potential differences in toxicity for the gastrointestinal, liver, and cardio-renal systems, as well as the individual’s risk factors, including age. When prescribing oral NSAIDs for low back pain, appropriate clinical assessment, ongoing monitoring of risk factors, and the use of gastroprotective treatment should be considered. It is recommended to prescribe oral NSAIDs for low back pain at the lowest effective dose for the shortest possible period of time. Weak opioids (with or without paracetamol) should only be considered for managing acute low back pain if an NSAID is contraindicated, not tolerated, or has been ineffective. Paracetamol alone should not be offered for managing low back pain.

Management of Non-Specific Lower Back Pain

Lower back pain is a common condition that affects many people. In 2016, NICE updated their guidelines on the management of non-specific lower back pain. The guidelines recommend NSAIDs as the first-line treatment for back pain. Lumbar spine x-rays are not recommended, and MRI should only be offered to patients where malignancy, infection, fracture, cauda equina or ankylosing spondylitis is suspected.

Patients with non-specific back pain are advised to stay physically active and exercise. NSAIDs are recommended as the first-line analgesia, and proton pump inhibitors should be co-prescribed for patients over the age of 45 years who are given NSAIDs. For patients with sciatica, NICE guidelines on neuropathic pain should be followed.

Other possible treatments include exercise programmes and manual therapy, but only as part of a treatment package including exercise, with or without psychological therapy. Radiofrequency denervation and epidural injections of local anaesthetic and steroid may also be considered for acute and severe sciatica.

In summary, the management of non-specific lower back pain involves encouraging self-management, staying physically active, and using NSAIDs as the first-line analgesia. Other treatments may be considered as part of a treatment package, depending on the severity of the condition.

A mutation in the fibrillin-1 protein is responsible for causing Marfan’s syndrome. This protein is coded by the Marfan syndrome gene (MSF1) located on chromosome 15. Connective tissue contains fibrillin, which is a glycoprotein. Synovial fluid contains hyaluronic acid, while elastin is an extracellular matrix protein found in connective tissue. Laminin is another extracellular matrix protein that forms part of the basement membrane.

The correct answer is synovial fluid that is sterile but has a high white blood cell count. The patient’s symptoms suggest reactive arthritis, which is a type of seronegative spondyloarthritis that typically affects the lower limbs and occurs after a gastrointestinal or urogenital infection. The condition is aseptic, meaning that no bacteria are present in the synovial fluid, but it can cause an increase in white blood cells, particularly polymorphonuclear leukocytes. Chlamydia trachomatis is an incorrect answer because while it may be the cause of reactive arthritis, the condition itself is aseptic. Staphylococcus aureus is also an incorrect answer because it is more commonly associated with septic arthritis, which is not suggested by the patient’s symptoms or test results. Negatively birefringent crystals are commonly seen in gout, while positively birefringent crystals are associated with calcium pyrophosphate deposition (pseudogout).

Reactive arthritis is a type of seronegative spondyloarthropathy that is associated with HLA-B27. It was previously known as Reiter’s syndrome, which was characterized by a triad of urethritis, conjunctivitis, and arthritis following a dysenteric illness during World War II. However, further studies revealed that patients could also develop symptoms after a sexually transmitted infection, now referred to as sexually acquired reactive arthritis (SARA). Reactive arthritis is defined as arthritis that occurs after an infection where the organism cannot be found in the joint. The post-STI form is more common in men, while the post-dysenteric form has an equal incidence in both sexes. The most common organisms associated with reactive arthritis are listed in the table below.

Management of reactive arthritis is mainly symptomatic, with analgesia, NSAIDs, and intra-articular steroids being used. Sulfasalazine and methotrexate may be used for persistent disease. Symptoms usually last for less than 12 months. It is worth noting that the term Reiter’s syndrome is no longer used due to the fact that Reiter was a member of the Nazi party.

Patients who have been diagnosed with antiphospholipid syndrome and have not had a history of thrombosis are typically prescribed low-dose aspirin. This condition is characterized by CLOTS, which stands for clots, livedo reticularis, obstetric complications, and thrombocytopenia. Diagnosis is confirmed through blood tests that show thrombocytopenia, a prolonged APTT, and positive antiphospholipid antibodies such as anti-cardiolipin, anti-beta-2-glycoprotein-1 antibodies, and lupus anticoagulant. Treatment for Raynaud’s phenomena, which causes painful and pale fingers and toes in cold temperatures, involves daily nifedipine. Lifelong LMWH is not recommended, but lifelong warfarin is recommended for patients with antiphospholipid syndrome who have experienced a previous thrombotic event. LMWH may be an option during pregnancy.

Antiphospholipid syndrome is a condition that can be acquired and is characterized by a higher risk of both venous and arterial thrombosis, recurrent fetal loss, and thrombocytopenia. It can occur as a primary disorder or as a secondary condition to other diseases, with systemic lupus erythematosus being the most common. One important point to remember for exams is that antiphospholipid syndrome can cause a paradoxical increase in the APTT. This is due to an ex-vivo reaction of the lupus anticoagulant autoantibodies with phospholipids involved in the coagulation cascade. Other features of this condition include livedo reticularis, pre-eclampsia, and pulmonary hypertension.

Antiphospholipid syndrome can also be associated with other autoimmune disorders, lymphoproliferative disorders, and, rarely, phenothiazines. Management of this condition is based on EULAR guidelines. Primary thromboprophylaxis involves low-dose aspirin, while secondary thromboprophylaxis depends on the type of thromboembolic event. Initial venous thromboembolic events require lifelong warfarin with a target INR of 2-3, while recurrent venous thromboembolic events require lifelong warfarin and low-dose aspirin. Arterial thrombosis should be treated with lifelong warfarin with a target INR of 2-3.

The symptoms observed and a positive Schirmer’s test indicate the possibility of Sjögren’s syndrome. The presence of anti-Ro and anti-La antibodies can aid in confirming the diagnosis.

Understanding Sjogren’s Syndrome

Sjogren’s syndrome is a medical condition that affects the exocrine glands, leading to dry mucosal surfaces. It is an autoimmune disorder that can either be primary or secondary to other connective tissue disorders, such as rheumatoid arthritis. The onset of the condition usually occurs around ten years after the initial onset of the primary disease. Sjogren’s syndrome is more common in females, with a ratio of 9:1. Patients with this condition have a higher risk of developing lymphoid malignancy, which is 40-60 times more likely.

The symptoms of Sjogren’s syndrome include dry eyes, dry mouth, vaginal dryness, arthralgia, Raynaud’s, myalgia, sensory polyneuropathy, recurrent episodes of parotitis, and subclinical renal tubular acidosis. To diagnose the condition, doctors may perform a Schirmer’s test to measure tear formation, check for hypergammaglobulinaemia, and low C4. Nearly 50% of patients with Sjogren’s syndrome test positive for rheumatoid factor, while 70% test positive for ANA. Additionally, 70% of patients with primary Sjogren’s syndrome have anti-Ro (SSA) antibodies, and 30% have anti-La (SSB) antibodies.

The management of Sjogren’s syndrome involves the use of artificial saliva and tears to alleviate dryness. Pilocarpine may also be used to stimulate saliva production. Understanding the symptoms and management of Sjogren’s syndrome is crucial for patients and healthcare providers to ensure proper treatment and care.

Exercise is typically beneficial for inflammatory back pain, such as that seen in ankylosing spondylitis. The patient’s symptoms, including morning stiffness and improvement with exercise, suggest an inflammatory cause, which is supported by the significantly elevated ESR. While there are several possible diagnoses, including seropositive and seronegative spondyloarthropathies, the most likely explanation is ankylosing spondylitis. Psoriatic arthritis is an incorrect answer, as the patient’s rash is more consistent with dermatitis than psoriasis. Osteoarthritis is also unlikely given the patient’s age and clinical history, while reactive arthritis is less likely due to the duration of symptoms and lack of urethritis or conjunctivitis.

Ankylosing spondylitis is a type of spondyloarthropathy that is associated with HLA-B27. It is more commonly seen in young males, with a sex ratio of 3:1, and typically presents with lower back pain and stiffness that develops gradually. The stiffness is usually worse in the morning and improves with exercise, while pain at night may improve upon getting up. Clinical examination may reveal reduced lateral and forward flexion, as well as reduced chest expansion. Other features associated with ankylosing spondylitis include apical fibrosis, anterior uveitis, aortic regurgitation, Achilles tendonitis, AV node block, amyloidosis, cauda equina syndrome, and peripheral arthritis (more common in females).

The symptoms indicate the possibility of scleroderma, and a detection of anti-centromere antibody can aid in confirming the diagnosis.

Understanding Systemic Sclerosis

Systemic sclerosis is a condition that affects the skin and other connective tissues, but its cause is unknown. It is more common in females, with three patterns of the disease. Limited cutaneous systemic sclerosis is characterised by Raynaud’s as the first sign, affecting the face and distal limbs, and associated with anti-centromere antibodies. CREST syndrome is a subtype of limited systemic sclerosis that includes Calcinosis, Raynaud’s phenomenon, oEsophageal dysmotility, Sclerodactyly, and Telangiectasia. Diffuse cutaneous systemic sclerosis affects the trunk and proximal limbs, associated with scl-70 antibodies, and has a poor prognosis. Respiratory involvement is the most common cause of death, with interstitial lung disease and pulmonary arterial hypertension being the primary complications. Renal disease and hypertension are also possible complications, and patients with renal disease should be started on an ACE inhibitor. Scleroderma without internal organ involvement is characterised by tightening and fibrosis of the skin, manifesting as plaques or linear. Antibodies such as ANA, RF, anti-scl-70, and anti-centromere are associated with different types of systemic sclerosis.

The flexor retinaculum is the only structure that is divided in the surgical treatment of carpal tunnel syndrome. It is important to protect all other structures during the procedure as damaging them could result in further injury or disability. The purpose of dividing the flexor retinaculum is to decompress the median nerve.

Understanding Carpal Tunnel Syndrome

Carpal tunnel syndrome is a condition that occurs when the median nerve in the carpal tunnel is compressed. Patients with this condition typically experience pain or pins and needles in their thumb, index, and middle fingers. In some cases, the symptoms may even ascend proximally. Patients often shake their hand to obtain relief, especially at night.

During an examination, doctors may observe weakness of thumb abduction and wasting of the thenar eminence (not the hypothenar). Tapping on the affected area may cause paraesthesia, which is known as Tinel’s sign. Flexion of the wrist may also cause symptoms, which is known as Phalen’s sign.

Carpal tunnel syndrome can be caused by a variety of factors, including idiopathic reasons, pregnancy, oedema (such as heart failure), lunate fracture, and rheumatoid arthritis. Electrophysiology tests may show prolongation of the action potential in both motor and sensory nerves.

Treatment for carpal tunnel syndrome may include a 6-week trial of conservative treatments, such as corticosteroid injections and wrist splints at night. If symptoms persist or are severe, surgical decompression (flexor retinaculum division) may be necessary.

Temporal arthritis frequently manifests in individuals with PMR.

Temporal arthritis, also known as giant cell arthritis, is a condition that affects medium and large-sized arteries and is of unknown cause. It typically occurs in individuals over the age of 50, with the highest incidence in those in their 70s. Early recognition and treatment are crucial to minimize the risk of complications, such as permanent loss of vision. Therefore, when temporal arthritis is suspected, urgent referral for assessment by a specialist and prompt treatment with high-dose prednisolone is necessary.

Temporal arthritis often overlaps with polymyalgia rheumatica, with around 50% of patients exhibiting features of both conditions. Symptoms of temporal arthritis include headache, jaw claudication, and tender, palpable temporal artery. Vision testing is a key investigation in all patients, as anterior ischemic optic neuropathy is the most common ocular complication. This results from occlusion of the posterior ciliary artery, leading to ischemia of the optic nerve head. Fundoscopy typically shows a swollen pale disc and blurred margins. Other symptoms may include aching, morning stiffness in proximal limb muscles, lethargy, depression, low-grade fever, anorexia, and night sweats.

Investigations for temporal arthritis include raised inflammatory markers, such as an ESR greater than 50 mm/hr and elevated CRP. A temporal artery biopsy may also be performed, and skip lesions may be present. Treatment for temporal arthritis involves urgent high-dose glucocorticoids, which should be given as soon as the diagnosis is suspected and before the temporal artery biopsy. If there is no visual loss, high-dose prednisolone is used. If there is evolving visual loss, IV methylprednisolone is usually given prior to starting high-dose prednisolone. Urgent ophthalmology review is necessary, as visual damage is often irreversible. Other treatments may include bone protection with bisphosphonates and low-dose aspirin.

The most common organism causing septic arthritis is Staphylococcus aureus. It is important to consider septic arthritis as a possible diagnosis when a joint appears red, hot, and swollen. While Neisseria gonorrhoeae is the most common cause in sexually active young adults, it is less likely in a 54-year-old. Salmonella typhimurium is a rare cause, but individuals with sickle cell disease are at higher risk for Salmonella spp septic arthritis. Staphylococcus epidermidis is a common cause in patients with a new prosthetic joint.

Septic Arthritis in Adults: Causes, Symptoms, and Treatment

Septic arthritis is a condition that occurs when bacteria infect a joint, leading to inflammation and pain. The most common organism that causes septic arthritis in adults is Staphylococcus aureus, but in young adults who are sexually active, Neisseria gonorrhoeae is the most common organism. The infection usually spreads through the bloodstream from a distant bacterial infection, such as an abscess. The knee is the most common location for septic arthritis in adults. Symptoms include an acute, swollen joint, restricted movement, warmth to the touch, and fever.

To diagnose septic arthritis, synovial fluid sampling is necessary and should be done before administering antibiotics if necessary. Blood cultures may also be taken to identify the cause of the infection. Joint imaging may also be used to confirm the diagnosis.

Treatment for septic arthritis involves intravenous antibiotics that cover Gram-positive cocci. Flucloxacillin or clindamycin is recommended if the patient is allergic to penicillin. Antibiotic treatment is typically given for several weeks, and patients are usually switched to oral antibiotics after two weeks. Needle aspiration may be used to decompress the joint, and arthroscopic lavage may be required in some cases.

When a patient is suspected to have cauda equina syndrome, it is crucial to conduct an urgent MRI of the spine for investigation. This is the preferred method of investigation to determine the cause of the syndrome. The most common cause is a herniated intravertebral disc that compresses the cauda equina. Other possible causes include primary or metastatic spinal tumors, infections like epidural abscesses, or hematomas. Imaging is necessary to identify the specific pathology causing the syndrome, determine the level of pathology, and guide the appropriate intervention. The article Cauda equina syndrome by Lavy C and Wilson-MacDonald J in BMJ 2009;338:b936 provides further information on this topic.

Cauda equina syndrome (CES) is a rare but serious condition that occurs when the nerve roots in the lower back are compressed. It is crucial to consider CES in patients who present with new or worsening lower back pain, as a late diagnosis can result in permanent nerve damage and long-term leg weakness and urinary/bowel incontinence. The most common cause of CES is a central disc prolapse, typically at L4/5 or L5/S1, but it can also be caused by tumors, infections, trauma, or hematomas. CES can present in various ways, and there is no single symptom or sign that can diagnose or exclude it. Possible features include low back pain, bilateral sciatica, reduced sensation in the perianal area, decreased anal tone, and urinary dysfunction. Urgent MRI is necessary for diagnosis, and surgical decompression is the recommended management.

The presence of the anti-Jo-1 antibody suggests that the patient is likely suffering from dermatomyositis, a condition characterized by muscle weakness in the proximal areas and a blue-purple rash on the face, upper eyelids, and trunk. The papules on the small joints of the hands, known as Gottron papules, are a telltale sign of this condition. While anti-CCP is often positive in rheumatoid arthritis, which causes pain and stiffness in the small joints of the hands and feet, anti-La and anti-Ro are commonly positive in Sjogren’s syndrome, which is characterized by dry mouth and eyes and swelling of the parotid gland.

Dermatomyositis is a condition that causes inflammation and muscle weakness, as well as distinct skin lesions. It can occur on its own or be associated with other connective tissue disorders or underlying cancers, particularly ovarian, breast, and lung cancer. Screening for cancer is often done after a diagnosis of dermatomyositis. Polymyositis is a variant of the disease that does not have prominent skin manifestations.

The skin features of dermatomyositis include a photosensitive macular rash on the back and shoulders, a heliotrope rash around the eyes, roughened red papules on the fingers’ extensor surfaces (known as Gottron’s papules), extremely dry and scaly hands with linear cracks on the fingers’ palmar and lateral aspects (known as mechanic’s hands), and nail fold capillary dilation. Other symptoms may include proximal muscle weakness with tenderness, Raynaud’s phenomenon, respiratory muscle weakness, interstitial lung disease (such as fibrosing alveolitis or organizing pneumonia), dysphagia, and dysphonia.

Investigations for dermatomyositis typically involve testing for ANA antibodies, which are positive in around 80% of patients. Approximately 30% of patients have antibodies to aminoacyl-tRNA synthetases, including antibodies against histidine-tRNA ligase (also called Jo-1), antibodies to signal recognition particle (SRP), and anti-Mi-2 antibodies.

Salmonella osteomyelitis is a common occurrence in sickle cell patients.

Among sickle cell patients, Salmonella is the leading cause of osteomyelitis. In contrast, Staphylococcus aureus is the most frequent cause in children. Haemophilus, Group A streptococcus, and Enterococcus are all less prevalent causes of osteomyelitis.

Understanding Osteomyelitis: Types, Causes, and Treatment

Osteomyelitis is a bone infection that can be classified into two types: haematogenous and non-haematogenous. Haematogenous osteomyelitis is caused by bacteria that enter the bloodstream and is usually monomicrobial. It is more common in children, with vertebral osteomyelitis being the most common form in adults. Risk factors include sickle cell anaemia, intravenous drug use, immunosuppression, and infective endocarditis. On the other hand, non-haematogenous osteomyelitis results from the spread of infection from adjacent soft tissues or direct injury to the bone. It is often polymicrobial and more common in adults, with risk factors such as diabetic foot ulcers, pressure sores, diabetes mellitus, and peripheral arterial disease.

Staphylococcus aureus is the most common cause of osteomyelitis, except in patients with sickle-cell anaemia where Salmonella species predominate. To diagnose osteomyelitis, MRI is the imaging modality of choice, with a sensitivity of 90-100%. Treatment for osteomyelitis involves a six-week course of flucloxacillin. Clindamycin is an alternative for patients who are allergic to penicillin.

In summary, osteomyelitis is a bone infection that can be caused by bacteria entering the bloodstream or spreading from adjacent soft tissues or direct injury to the bone. It is more common in children and adults with certain risk factors. Staphylococcus aureus is the most common cause, and MRI is the preferred imaging modality for diagnosis. Treatment involves a six-week course of flucloxacillin or clindamycin for penicillin-allergic patients.